Drug
Rgh 706
Rgh 706: highest development phase Phase 2, developed by Gedeon Richter. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| RGH-706 NCT05322096 | Phase 2 | Prader-Willi Syndrome |
Latest
No recent events.
Follow Rgh 706 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.